跳至主要内容
临床试验/IRCT2015061521970N2
IRCT2015061521970N2已完成2 期

Clinical trial comparing the effects of low dose aspirin and placebo on clinical improvement of moderate to severe aspirin-sensitive asthmatic patients with chronic rhinosinusitis and nasal polyposis

Vice chancellor for research, Iran Uiversity of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 18 to 65 years old; clinical symptoms of chronic rhinosinusitis with nasal polyposis which confirmed by sinus CT scan; moderate to severe asthma according to the history, spirometric findings and Expert Panel Report 3 (EPR-3) guidelines; receiving the full course of standard treatments for rhinosinusitis and asthma according to the EPR-3 guidelines for 3 months before entering study
  • Exclusion criteria: presence of serious underlying disease such as bleeding disorders, gastrointestinal, rheumatologic, cancer, heart, kidney, liver and mental diseases; medical history of immediate hypersensitivity reactions to aspirin and nonsteroidal anti-inflammatory drugs; Forced Expiratory Volume in the first second (FEV1) less than 70% at the time of aspirin challenge; pregnancy; breast-feeding; the use of systemic and topical beta-blocker, angiotensin-converting enzyme inhibitor, angiotensinogen ? receptor blocker, warfarin; mastocytosis; nonadherent patients; patients with high risk jobs or lifestyle

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Iran Uiversity of Medical Sciences

相似试验